Literature DB >> 33679616

MAMs Protect Against Ectopic Fat Deposition and Lipid-Related Kidney Damage in DN Patients.

Ming Yang1, Yachun Han1, Shilu Luo1, Xiaofen Xiong1, Xuejing Zhu1, Hao Zhao1, Na Jiang1, Ying Xiao1, Ling Wei1, Chenrui Li1, Jinfei Yang1, Lin Sun1.   

Abstract

Ectopic fat deposition (EFD) in the kidney plays a key role in the development of diabetic nephropathy (DN). Mitochondria-associated ER membranes (MAMs) are structures that connect to the endoplasmic reticulum (ER) and are involved in lipid metabolism. However, there are few studies on MAMs in the field of kidney disease, and the relationship between EFD and MAMs in DN is still unclear. In this study, increased EFD in the kidneys of DN patients was observed, and analysis showed that the degree of EFD was positively correlated with renal damage. Then, the MAMs were quantified by an in situ proximity ligation assay (PLA). The MAMs in the kidneys were found to gradually decrease through the different stages of DN, while the expression of ADRP (a marker of lipid droplets) and tubulointerstitial damage increased. Moreover, correlation analysis showed that the MAMs were negatively correlated with serum lipid levels, the EFD in the kidney and renal damage. Finally, we observed decreased expression of MAM-control proteins (DsbA-L, PACS-2, and MFN-2) in different stages of DN and they were associated with lipid deposition and renal damage. These data showed that the destruction of MAMs in DN might be the cause of EFD and interstitial damage in the kidney.
Copyright © 2021 Yang, Han, Luo, Xiong, Zhu, Zhao, Jiang, Xiao, Wei, Li, Yang and Sun.

Entities:  

Keywords:  diabetic nephropathy (DN); ectopic fat deposition; lipid metabolism; mitochondria; mitochondria-associated ER membranes (MAMs)

Mesh:

Substances:

Year:  2021        PMID: 33679616      PMCID: PMC7933555          DOI: 10.3389/fendo.2021.609580

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  30 in total

Review 1.  The life of lipid droplets.

Authors:  Tobias C Walther; Robert V Farese
Journal:  Biochim Biophys Acta       Date:  2008-11-07

Review 2.  Role of Endoplasmic Reticulum-Mitochondria Communication in Type 2 Diabetes.

Authors:  Jennifer Rieusset
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 3.  Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease.

Authors:  Aiko P J de Vries; Piero Ruggenenti; Xiong Z Ruan; Manuel Praga; Josep M Cruzado; Ingeborg M Bajema; Vivette D D'Agati; Hildo J Lamb; Drazenka Pongrac Barlovic; Radovan Hojs; Manuela Abbate; Rosa Rodriquez; Carl Erik Mogensen; Esteban Porrini
Journal:  Lancet Diabetes Endocrinol       Date:  2014-05       Impact factor: 32.069

4.  Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

Authors:  Ian H de Boer; Tessa C Rue; Patricia A Cleary; John M Lachin; Mark E Molitch; Michael W Steffes; Wanjie Sun; Bernard Zinman; John D Brunzell; Neil H White; Ronald P Danis; Matthew D Davis; Dean Hainsworth; Larry D Hubbard; David M Nathan
Journal:  Arch Intern Med       Date:  2011-03-14

5.  Pathologic classification of diabetic nephropathy.

Authors:  Thijs W Cohen Tervaert; Antien L Mooyaart; Kerstin Amann; Arthur H Cohen; H Terence Cook; Cinthia B Drachenberg; Franco Ferrario; Agnes B Fogo; Mark Haas; Emile de Heer; Kensuke Joh; Laure H Noël; Jai Radhakrishnan; Surya V Seshan; Ingeborg M Bajema; Jan A Bruijn
Journal:  J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 10.121

6.  Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.

Authors:  Emily Tubbs; Pierre Theurey; Guillaume Vial; Nadia Bendridi; Amélie Bravard; Marie-Agnès Chauvin; Jingwei Ji-Cao; Fabien Zoulim; Birke Bartosch; Michel Ovize; Hubert Vidal; Jennifer Rieusset
Journal:  Diabetes       Date:  2014-06-19       Impact factor: 9.461

7.  Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.

Authors:  Wai Han Yiu; Rui Xi Li; Dickson W L Wong; Hao Jia Wu; Kam Wa Chan; Loretta Y Y Chan; Joseph C K Leung; Kar Neng Lai; Steven H Sacks; Wuding Zhou; Sydney C W Tang
Journal:  Nephrol Dial Transplant       Date:  2018-08-01       Impact factor: 5.992

8.  DsbA-L ameliorates high glucose induced tubular damage through maintaining MAM integrity.

Authors:  Ming Yang; Li Zhao; Peng Gao; Xuejing Zhu; Yachun Han; Xianghui Chen; Li Li; Ying Xiao; Ling Wei; Chenrui Li; Li Xiao; Shuguang Yuan; Fuyou Liu; Lily Q Dong; Yashpal S Kanwar; Lin Sun
Journal:  EBioMedicine       Date:  2019-05-03       Impact factor: 8.143

9.  Inflammation Induces Lipid Deposition in Kidneys by Downregulating Renal PCSK9 in Mice with Adriamycin-Induced Nephropathy.

Authors:  Gaofu Zhang; Qiu Li
Journal:  Med Sci Monit       Date:  2019-07-18

10.  Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.

Authors:  Chi-Juei Jeng; Yi-Ting Hsieh; Chung-May Yang; Chang-Hao Yang; Cheng-Li Lin; I-Jong Wang
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

View more
  6 in total

1.  AKT/PACS2 Participates in Renal Vascular Hyperpermeability by Regulating Endothelial Fatty Acid Oxidation in Diabetic Mice.

Authors:  Zhihao Shu; Shuhua Chen; Hong Xiang; Ruoru Wu; Xuewen Wang; Jie Ouyang; Jing Zhang; Huiqin Liu; Alex F Chen; Hongwei Lu
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

2.  The CXCL1-CXCR2 Axis Mediates Tubular Injury in Diabetic Nephropathy Through the Regulation of the Inflammatory Response.

Authors:  Hanfen Tang; Ming Yang; Yinghong Liu; Hong Liu; Lin Sun; Panai Song
Journal:  Front Physiol       Date:  2021-12-16       Impact factor: 4.566

Review 3.  The Mitochondrial-Associated Endoplasmic Reticulum Membrane and Its Role in Diabetic Nephropathy.

Authors:  Lihua Ni; Cheng Yuan
Journal:  Oxid Med Cell Longev       Date:  2021-11-05       Impact factor: 6.543

4.  PACS-2 attenuates diabetic kidney disease via the enhancement of mitochondria-associated endoplasmic reticulum membrane formation.

Authors:  Mei Xue; Ting Fang; Hongxi Sun; Ying Cheng; Ting Li; Chaofei Xu; Chao Tang; Xiaohuan Liu; Bei Sun; Liming Chen
Journal:  Cell Death Dis       Date:  2021-11-26       Impact factor: 8.469

Review 5.  Intermittent Fasting-A Healthy Dietary Pattern for Diabetic Nephropathy.

Authors:  Ming Yang; Wei Chen; Liyu He; Di Liu; Li Zhao; Xi Wang
Journal:  Nutrients       Date:  2022-09-26       Impact factor: 6.706

Review 6.  Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction.

Authors:  Simeng Liu; Yanggang Yuan; Yi Xue; Changying Xing; Bo Zhang
Journal:  Front Cell Dev Biol       Date:  2022-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.